A non-canonical metabolic link between PCSK9 and ENO1 K71 lactylation in colon cancer
Lactylation modification regulates tumor metabolism and malignant progression. Proprotein convertase subtilisin/kexin type 9 (PCSK9) modulates lactylation and intracellular lactate levels, but its role in glucose metabolism remains unclear. The 4D label‑free lactylproteomics was performed on PCSK9‑knockdown colon cancer cells to screen lactylation targets. Enolase 1 (ENO1) lactylation were verified by immunoprecipitation and Western blot (WB). Site‑directed mutagenesis was used to generate the ENO1 K71R mutant, which abolishes the K71 lactylation acceptor site and serves as a lactylation‑deficient surrogate. Lactate levels and ENO1 enzymatic activity were measured, and core Kla‑regulatory enzymes were assessed by WB. A total of 1128 differential lactylation sites (614 proteins) were identified, mostly downregulated and enriched in glycolytic pathways. Among three glycolytic candidates (ENO1, ALDOA, PGK1), ENO1 showed reduced Kla upon PCSK9 knockdown, accompanied by decreased enzyme activity and lactate production-without altering total ENO1 protein. The ENO1‑K71R mutant, which eliminates the K71 lactylation acceptor site and functions as a lactylation‑deficient surrogate, displayed diminished ENO1 Kla, compromised enzymatic activity, and lowered lactate production. PCSK9 knockdown did not affect canonical Kla‑regulatory enzymes (HDAC1, HDAC2, p300/CBP) protein levels. PCSK9 knockdown is associated with decreased ENO1 K71 Kla and reduced glycolytic activity, independent of canonical Kla‑regulatory enzymes. These findings uncover a non‑canonical metabolic function of PCSK9 in colon cancer.
Authors
- Jin Meng (ORCID: https://orcid.org/0000-0002-3385-8383)
- Guangzhu SU
- Zhenhua Dong
- Huihui Ding
- Lu Wang
Institutions
- Shandong Provincial Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1038/s41598-026-75484-2
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00